Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-09
2011-11-22
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S086000
Reexamination Certificate
active
08063061
ABSTRACT:
The disclosure relates to compounds of formula (I):wherein R1, R2, R3, R4, are R5are as defined in the disclosure; their preparation method, compositions containing the same and therapeutic use thereof.
REFERENCES:
patent: 4263304 (1981-04-01), Ishizumi et al.
patent: 4835160 (1989-05-01), Bisagni et al.
patent: 5880126 (1999-03-01), Skuballa et al.
patent: 6503888 (2003-01-01), Kaplitt et al.
patent: 6967203 (2005-11-01), Bourrie et al.
patent: 2002/0156016 (2002-10-01), Minuk
patent: 2004/0122036 (2004-06-01), Bourrie et al.
patent: 2005/0222192 (2005-10-01), Bourrie et al.
patent: 2005/0288318 (2005-12-01), Bourrie et al.
patent: 2007/0129365 (2007-06-01), Bourrie et al.
patent: 2008/0214538 (2008-09-01), Bourrie et al.
patent: 2009/0042924 (2009-02-01), Bourrie et al.
patent: 2 003 999 (1969-11-01), None
patent: 2 765 581 (1999-01-01), None
patent: 2 765 582 (1999-01-01), None
patent: 2 846 329 (2004-04-01), None
patent: 1 268 772 (1972-03-01), None
patent: 833971 (1981-05-01), None
patent: WO 99/51597 (1999-10-01), None
patent: WO 01/09129 (2001-02-01), None
patent: WO 02/087574 (2002-11-01), None
patent: WO 02/087575 (2002-11-01), None
patent: WO 2004/037821 (2004-05-01), None
patent: WO 2004/041817 (2004-05-01), None
patent: WO 2005/108398 (2005-11-01), None
Burger et al, Zum Reaktionsverhalten von Trifluormethyl-Gruppen Synthese von 1,3-Azolen aus Trifluormethyl-substituierten Hetero-l,3-dienen, Chem. Ber., 1982 (115) pp. 2494-2507.
Colomb et al, Nuclear Texture Parameters as Discriminant Factors in Cell Cycle and Drug Sensitivity Studies, Cytometry, 1991 (12) pp. 15-25.
Derocq et al, The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines, FEBS Letters, 1998 (425) pp. 419-425.
Hassner et al, 4,5- and 2,5-additions to oxazoles, Tetrahedron, 1989 (45) 19 pp. 6249-6262.
Kruger et al, 2-Haloethyl 1-Thioglycosides as New Tools in glycoside Syntheses. Part 1: Preparation, Characteristics, General Reactions, Collect. Czech. Chem. Commun., 2004 (69) pp. 1843-1876.
Estenne et al, Derwent Patent Abstract No. 199909 (2003), (Abstract of FR 2 765 582).
Furihata, C., et al., In Vivo Short-Term Assays for Tumor Initiation and Promotion in the Grandular Stomach of Fischer Rats, Mutation Research, (1995), vol. 339, No. 1, pp. 15-35.
Furihata, C., et al., Unscheduled DNA Synthesis in Rat Stomach-Short-Term Assay of Potential Stomach Carcinogens, Banbury Report, (1982), vol. 13, pp. 123-135.
Goldman M.D., et al., Cecil, Textbook of Medicine, 21st edition, vol. 1, published 2000 by W.B. Saunders Co. (PA), pp. 1060-1074.
Golovko, T., et al., A New Approach to the Synthesis of Functionally-Substituted Pyrido 2, 3-D Indoles, Mendeleev Communications, (1995), vol. 6, pp. 226-227.
Goodman & Gilman, Section X. Chemotherapy of Neoplastic Diseases, Goodman & Gilman's the Pharmacological Basis of Therapeutics, 9th Ed., (1996) pp. 1225-1232 and pp. 1269-1271.
Molina, P., et al., Annulation of Pyridine to Indole by a Tandem Aza-Wittig/Electrocyclization Strategy: Synthesis of Pyrido 2, 3-B Indoles, Synthesis, (1989), vol. 11, pp. 878-880.
Nicholson-Guthrie et al, Urine GABA Levels in Ovarian Cancer Patients: elevated GABA in malignancy, Cancer Letters, vol. 162, Issue 1, (2001), pp. 27-30.
Bourrie Bernard
Casellas Pierre
Ciapetti Paola
Deroco Jean-Marie
Jegham Samir
Anderson Rebecca
Sanofi-Aventis
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
6-heteroarylpyridoindolone derivatives, their preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-heteroarylpyridoindolone derivatives, their preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-heteroarylpyridoindolone derivatives, their preparation... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4312966